Genomics and those working in that exciting area have led the news lately through the publication this week of the sequence of the human genome.

That breakthrough scientific milestone and other areas of the industry are profiled in a new report now available from BioWorld called, "2001 Genomics Review: Moving From Discovery to Drugs."

The 330-page report includes profiles of 37 public companies - 15 of which went public in 2000 - and 33 private companies. It also includes details on more than 1,000 genomics collaborations, and features stories on proteomics, bioinformatics, the state of the industry and ethics.

The report is current through 2000, and in some cases into 2001.

For more information on the book or to order, call 1-800-688-2421 or (404) 262-5476, or visit the BioWorld Online site at